Previous close | 2.2000 |
Open | N/A |
Bid | 0.8500 |
Ask | 5.9000 |
Strike | 430.00 |
Expiry date | 2024-05-17 |
Day's range | 2.2000 - 2.2000 |
Contract range | N/A |
Volume | |
Open interest | 1 |
First Quarter Results Show Revenue Decline but Strong Dupixent and Libtayo Sales Growth
It is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent performance, when its stock...
Regeneron Pharmaceuticals earnings and sales missed first-quarter estimates early Thursday. Shares fell slightly.